A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India

References

• Economic impact of the COVID-19 pandemic. https://en.wikipedia.org/wiki/Economic_impact_of_the_COVID-19_pandemic
   Google Scholar
• Gebru AA, Birhanu T, Wendimu E, Ayalew AF, Mulat S, Abasimel HZ, et al. Global burden of COVID-19: situational analyis and review. Hum Antibodies. 2021;29:139–148. doi:10.3233/HAB-200420.
   PubMedGoogle Scholar
• Chong WH, Saha BK, Ramani A, Chopra A. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia [published online ahead of print, 2021 Mar 11]. Infection. 2021;1–15.
   Web of Science ®Google Scholar
• Song G, Liang G, Liu W. Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China. Mycopathologia. 2020;185:599–606. doi:10.1007/s11046-020-00462-9.
   PubMed Web of Science ®Google Scholar
• Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India [published online ahead of print, 2021 May 21]. Diabetes Metab Syndr. 2021;15:102146. doi:10.1016/j.dsx.2021.05.019.
   PubMed Web of Science ®Google Scholar
• Riley TT, Muzny CA, Swiatlo E, Legendre DP. Breaking the mold: a review of mucormycosis and current pharmacological treatment options. Ann Pharmacother. 2016;50:747–757. doi:10.1177/1060028016655425.
   PubMed Web of Science ®Google Scholar
• Mignogna MD, Fortuna G, Leuci S, Adamo D, Ruoppo E, Siano M, et al. Mucormycosis in immunocompetent patients: a case-series of patients with maxillary sinus involvement and a critical review of the literature. Int J Infect Dis. 2011;15:e533–e540. doi:10.1016/j.ijid.2011.02.005.
   PubMed Web of Science ®Google Scholar
• Amanati A, Barzegar H, Pouladfar G, Dashti AS, Abtahi AB, Khademi B, et al. Orbital mucormycosis in immunocompetent children; review of risk factors, diagnosis, and treatment approach. BMC Infect Dis. 2020;20:770. doi:10.1186/s12879-020-05460-2.
   PubMed Web of Science ®Google Scholar
• Sridhara SR, Paragache G, Panda NK, Chakrabarti A. Mucormycosis in immunocompetent individuals: an increasing trend. J Otolaryngol. 2005;34:402–406. doi:10.2310/7070.2005.34607.
   PubMedGoogle Scholar
• Prakash H, Chakrabarti A. Epidemiology of Mucormycosis in India. Microorganisms. 2021;9:523. doi:10.3390/microorganisms9030523.
   PubMed Web of Science ®Google Scholar
• Patel A, Kaur H, Xess I, Michael JS, Savio J, Rudramurthy S, et al. A multi-centre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. Clin Microbiol Infect. 2020;26:944.e9–944.e15. doi:10.1016/j.cmi.2019.11.021.
   Web of Science ®Google Scholar
• Raut A, Huy NT. Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave? Lancet Respir Med. 2021;9:(8):e77. S2213-2600(21)00265-4. doi:10.1016/S2213-2600(21)00265-4.
   PubMed Web of Science ®Google Scholar
• Moorthy A, Gaikwad R, Krishna S, Hegde R, Tripathi KK, Kale PG, et al. SARS-CoV-2, uncontrolled diabetes and corticosteroids-an unholy trinity in invasive fungal infections of the maxillofacial region? A retrospective, multi-centric analysis. J Maxillofac Oral Surg. 2021:1–8. doi:10.1007/s12663-021-01532-1.
   Web of Science ®Google Scholar
• Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. Mucor in a viral land: a tale of two pathogens. Indian J Ophthalmol. 2021;69:244–252. doi:10.4103/ijo.IJO_3774_20.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Gokhale T, Choudhury SS, Deb AK. COVID-19 and orbital mucormycosis. Indian J Ophthalmol. 2021;69:1002–1004. doi:10.4103/ijo.IJO_3763_20.
   PubMed Web of Science ®Google Scholar
• Nehara HR, Puri I, Singhal V, Ih S, Bishnoi BR, Sirohi P. Rhinocerebral mucormycosis in COVID-19 patient with diabetes a deadly trio: case series from the north-western part of India. Indian J Med Microbiol. 2021;39:S0255-0857(21)04111–6. doi:10.1016/j.ijmmb.2021.05.009.
   PubMed Web of Science ®Google Scholar
• Mehta S, Pandey A. Rhino-orbital mucormycosis associated with COVID-19. Cureus. 2020;12:e10726. doi:10.7759/cureus.10726.
   PubMed Web of Science ®Google Scholar
• Rao R, Shetty AP, Nagesh CP. Orbital infarction syndrome secondary to rhino-orbital mucormycosis in a case of COVID-19: clinico-radiological features. Indian J Ophthalmol. 2021;69:1627–1630. doi:10.4103/ijo.IJO_1053_21.
   PubMed Web of Science ®Google Scholar
• Ravani SA, Agrawal GA, Leuva PA, Modi PH, Amin KD. Rise of the Phoenix: mucormycosis in COVID-19 times. Indian J Ophthalmol. 2021;69:1563–1568. doi:10.4103/ijo.IJO_310_21.
   PubMed Web of Science ®Google Scholar
• Revannavar SM, S PS, Samaga L, V VK. COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world? BMJ Case Rep. 2021;14:e241663. doi:10.1136/bcr-2021-241663.
   PubMedGoogle Scholar
• Saldanha M, Reddy R. Vincent MJ.Paranasal Mucormycosis in COVID-19 Patient. Indian J Otolaryngol Head Neck Surg. 2021;1–4. doi:10.1007/s12070-021-02574-0.
   PubMed Web of Science ®Google Scholar
• Sen M, Honavar SG, Bansal R, Sengupta S, Rao R, Kim U, et al. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - collaborative OPAI-IJO study on mucormycosis in COVID-19 (COSMIC), report 1. Indian J Ophthalmol. 2021;69:1670–1692. doi:10.4103/ijo.IJO_1565_21.
   PubMed Web of Science ®Google Scholar
• Jain VK, Iyengar KP, Vaishya R. Differences between first wave and second wave of COVID-19 in India. Diabetes Metab Syndr. 2021;S1871-4021(21)00147–8.
   Web of Science ®Google Scholar
• Honavar SG. Rhino-orbito-cerebral mucormycosis – guidelines for diagnosis, staging, and management. Indian J Ophthalmol. 2021;69:1361–1365. doi:10.4103/ijo.IJO_1165_21.
   PubMed Web of Science ®Google Scholar
• Bayram N, Ozsaygılı C, Sav H, Tekin Y, Gundogan M, Pangal E, et al. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations. Jpn J Ophthalmol. 2021;31:1–11.
   Google Scholar
• Veisi A, Bagheri A, Eshaghi M, Rikhtehgar MH, Rezaei Kanavi M, Farjad R. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: a case report. Eur J Ophthalmol. 2021:11206721211009450. doi:10.1177/11206721211009450. Epub ahead of print.
   Web of Science ®Google Scholar
• Ashour MM, Abdelaziz TT, Ashour DM, Askoura A, Saleh MI, Mahmoud MS. Imaging spectrum of acute invasive fungal rhino-orbital-cerebral sinusitis in COVID-19 patients: a case series and a review of literature. J Neuroradiol. 2021;48:(5):319–324. S0150-9861(21)00130-9. Epub ahead of print. doi:10.1016/j.neurad.2021.05.007.
   PubMed Web of Science ®Google Scholar
• Maini A, Tomar G, Khanna D, Kini Y, Mehta H, Bhagyasree V. Sino-orbital mucormycosis in a COVID-19 patient: a case report. Int J Surg Case Rep. 2021;82:105957. doi:10.1016/j.ijscr.2021.105957.
   PubMed Web of Science ®Google Scholar
• Werthman-Ehrenreich A. Mucormycosis with orbital compartment syndrome in a patient with COVID-19. Am J Emerg Med. 2021;42:264.e5–264.e8. doi:10.1016/j.ajem.2020.09.032.
   PubMed Web of Science ®Google Scholar
• Mekonnen ZK, Ashraf DC, Jankowski T, Grob SR, Vagefi MR, Kersten RC, et al. Acute invasive rhino-orbital mucormycosis in a patient with COVID-19-associated acute respiratory distress syndrome. Ophthalmic Plast Reconstr Surg. 2021;37:e40–e80. doi:10.1097/IOP.0000000000001889.
   PubMed Web of Science ®Google Scholar
• Waizel-Haiat S, Guerrero-Paz JA, Sanchez-Hurtado L, Calleja-Alarcon S, Romero-Gutierrez L. A case of fatal rhino-orbital mucormycosis associated with new onset diabetic ketoacidosis and COVID-19. Cureus. 2021;13:e13163. doi:10.7759/cureus.13163.
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Dhaliwal M. Epidemiology of mucormycosis in India. Curr Fungal Infect Rep. 2013;7:287–292. doi:10.1007/s12281-013-0152-z.
   Google Scholar
• Mortaz E, Tabarsi P, Varahram M, Folkerts G, Adcock IM. The immune response and immunopathology of COVID-19. Front Immunol. 2020;11:2037. doi:10.3389/fimmu.2020.02037.
   PubMed Web of Science ®Google Scholar
• Patel A, Agarwal R, Rudramurthy SM, Shevkani M, Xess I, Sharma R, et al. Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India. Emerg Infect Dis. 2021;27:2349–2359. doi:10.3201/eid2709.210934.
   PubMed Web of Science ®Google Scholar
• Raju R, P V, Biatris PS, Sjuc J. Therapeutic role of corticosteroids in COVID-19: a systematic review of registered clinical trials. Futur J Pharm Sci. 2021;7:67. doi:10.1186/s43094-021-00217-3.
   PubMed Web of Science ®Google Scholar
• Müller JA, Groß R, Conzelmann C, Kruger J, Merle U, Steinhart J, et al. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat Metab. 2021;3:149–165. doi:10.1038/s42255-021-00347-1.
   PubMedGoogle Scholar
• Hayden MR. An immediate and long-term complication of COVID-19 may be type 2 diabetes mellitus: the central role of β-cell dysfunction, apoptosis and exploration of possible mechanisms. Cells. 2020;9:2475. doi:10.3390/cells9112475.
   PubMed Web of Science ®Google Scholar
• Habib HM, Ibrahim S, Zaim A, Ibrahim WH. The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators. Biomed Pharmacother. 2021;136:111228. doi:10.1016/j.biopha.2021.111228.
   PubMed Web of Science ®Google Scholar
• Doroftei B, Ciobica A, Ilie OD, Maftei R, Ilea C. Mini-review discussing the reliability and efficiency of COVID-19 vaccines. Diagnostics (Basel). 2021;11:579. doi:10.3390/diagnostics11040579.
   PubMedGoogle Scholar
• Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25:26–34. doi:10.1016/j.cmi.2018.07.011.
   PubMed Web of Science ®Google Scholar
• Jiang N, Zhao G, Yang S, Lin J, Hu L, Che C, et al. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially. BMC Ophthalmol. 2016;16:10. doi:10.1186/s12886-016-0189-1.
   PubMed Web of Science ®Google Scholar
• Kashkouli MB, Abdolalizadeh P, Oghazian M, Hadi Y, Karimi N, Ghazizadeh M. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis. Br J Ophthalmol. 2019;103:1460–1465. doi:10.1136/bjophthalmol-2018-312688.
   PubMed Web of Science ®Google Scholar